Article

Dr. Schallhorn joins ClearView Eye & Laser Medical Center

Capt. Steven Schallhorn, MD, recently retired from the U.S. Navy, joins the ClearView Eye & Laser Medical Center in San Diego. Beginning May 1, Dr. Schallhorn will be providing vision-correction surgery along with FDA clinical research at the center.

Capt. Steven Schallhorn, MD, recently retired from the U.S. Navy, joins the ClearView Eye & Laser Medical Center in San Diego. Beginning May 1, Dr. Schallhorn will be providing vision-correction surgery along with FDA clinical research at the center.

Dr. Schallhorn served in the U.S. military for 30 years where he was director of the cornea service and refractive surgery at the Naval Medical Center San Diego (Balboa Hospital) and the refractive surgery program manager for the U.S. Navy. Dr. Schallhorn was the ophthalmologist selected to evaluate the Chief of Naval Operations, as well as Surgeon General of the Navy, Admirals, Naval Aviators, SEALS, Sailors, and Marines. He conceived of and initiated the first refractive surgery programs for the U.S. Armed Forces to study the visual recovery and performance characteristics of PRK and LASIK before the FDA approved excimer lasers.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
I. Paul Singh, MD, speaks about glaucoma treatment and successful ophthalmic / optometric comanagement at the 19th Annual Controversies in Modern Eye Care meeting
© 2025 MJH Life Sciences

All rights reserved.